Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Acne Vulgaris
Interventions
DRUG

ACZONE Gel, 5%

DRUG

Vehicle

Trial Locations (29)

10032

Columbia University Medical Center Department of Dermatology, New York

11203

Department of Dermatology SUNY Downstate Medical Center, Brooklyn

19103

Paddington Testing Clinic, Philadelphia

20010

Dermatology Associates, PC at the Washington Hospital Center, Washington D.C.

20060

Howard University Hospital Department of Dermatology, Washington D.C.

23507

Virginia Clinical Research, Norfolk

24501

The Education and Research Foundation, Inc., Lynchburg

28209

Metrolina Medical Research, Charlotte

30263

MedaPhase, Inc., Newnan

33024

University Clinical Research, Inc, Pembroke Pines

33175

FXM Research, Miami

35209

Radiant Research, Inc., Birmingham

37203

Dermatology Research Associates, Nashville

37917

Dermatology Associates of Knoxville, Knoxville

45219

Universtiy Dermatology Consultants, Inc., Cincinnati

48202

Henry Ford Medical Center - New Center One, Detroit

53209

Advanced Healthcare, SC, Milwaukee

63110

Washington University Dermatology Clinical Trials Unit, St Louis

68144

Skin Specialists, PC, Omaha

75234

Research Across America, Dallas

77056

Suzanne Bruce and Associates, PA, Houston

77701

DiscoveResearch, Inc., Beaumont

77802

J&S Studies, Inc., Bryan

78759

DermResearch, Inc., Austin

92123

Therapeutics Clinical Research, San Diego

94115

Department of Dermatology, University of California, San Francisco, San Francisco

02135

Boston Clinical Trials, Boston

19107-6129

Society Hill Dermatology, Philadelphia

29907'

Okatie Research Center, LLC, Beaufort

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY